| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 276.86B | 254.39B | 235.23B | 217.85B | 209.32B |
| Gross Profit | 227.81B | 222.76B | 205.62B | 191.74B | 181.07B |
| EBITDA | 66.03B | 57.20B | 51.94B | 45.44B | 38.82B |
| Net Income | 28.48B | 26.59B | 24.67B | 21.47B | 17.79B |
Balance Sheet | |||||
| Total Assets | 1.14T | 1.05T | 1.00T | 961.95B | 920.03B |
| Cash, Cash Equivalents and Short-Term Investments | 53.55B | 49.25B | 64.56B | 52.43B | 39.72B |
| Total Debt | 716.25B | 636.48B | 594.36B | 583.06B | 527.16B |
| Total Liabilities | 896.45B | 806.71B | 749.87B | 715.39B | 657.98B |
| Stockholders Equity | 244.19B | 246.14B | 253.25B | 246.14B | 261.61B |
Cash Flow | |||||
| Free Cash Flow | -65.90B | -17.59B | 23.21B | 7.02B | 2.99B |
| Operating Cash Flow | -48.40B | -4.48B | 38.00B | 16.72B | 11.52B |
| Investing Cash Flow | 1.39B | -13.66B | -18.27B | -22.38B | -13.76B |
| Financing Cash Flow | 51.31B | 2.84B | -7.88B | 18.26B | 770.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | ¥621.58B | 10.12 | 9.13% | 2.79% | 10.98% | 0.22% | |
63 Neutral | ¥703.88B | 8.86 | 7.97% | 3.48% | 6.29% | 147.90% | |
61 Neutral | ¥323.64B | 15.32 | 3.46% | 3.04% | 7.13% | 34.82% | |
60 Neutral | ¥506.62B | 17.63 | 11.30% | 3.66% | 8.83% | 10.44% | |
56 Neutral | ¥159.97B | 40.26 | ― | 4.42% | 1.18% | -28.29% |